Coal India, Power Grid, SBI Cards and other stocks to watch out for on June 18

Jun 18, 2021

By: Rounak Jain

Coal India

It is considering raising prices of coal due to an increase in costs and capital expenditure. Its capex for the financial year 2021-22 is budgeted at ₹17,000 crore.

Credit: BCCL

Power Grid Corporation

It reported a 6 percent increase in net profit in the March 2021 quarter to ₹3,526 crore. Revenue increased to ₹10,816 crore from ₹10,508 crore a year ago. It also declared a bonus of 1 share for every 3 shares held.

Credit: BCCL

SBI Cards and Payment Services

One of its shareholders, CA Rover Holdings, is offering 48 million shares in a price range of ₹1,002-1,041, which is at a discount of 1 to 4.7 percent compared to the closing price on June 17.

Credit: SBI-Cards

Adani Transmission

It has set up a new subsidiary ATL HVDC that will look after the transmission, supply and distribution of power and other related services.

Credit: Adani-Transmission

Earnings today

Ashoka Buildcon, GMR Infrastructure, Jubilant Industries, Hinduja Global Solutions, Insecticides India, Gujarat Fluorochemicals, PSP Projects, Welspun Specialty Solutions.

Credit: Pixabay

Gati

The logistics company has approved the allotment of shares on a preferential basis to raise ₹10 crore, in addition to share warrants worth ₹70 crore.

Credit: Gati

Nazara Technologies

It will acquire a 69.82 percent stake in Publishme, which is a games marketing agency, for ₹20 crore.

Credit: Nazara-Technologies

Natco Pharma

Its March 2021 quarter net profit fell by nearly half to ₹53 crore. Revenue fell by over 27 percent to ₹331 crore, year-on-year.

Credit: Natco-Pharma

Tube Investments India

It reported a near-three time surge in net profit in the March 2021 quarter to ₹160 crore. Revenue more than doubled to ₹2,733 crore from ₹1,031 crore, year-on-year.

Credit: Tube-Investments-India

Novartis India

Its March 2021 quarter net profit jumped by 43 percent to ₹9.7 crore, while revenue witnessed a relatively muted jump to ₹99 crore from ₹94 crore, year-on-year.

Credit: Novartis-India

Headaches, acidity, eyesight issues & more — working for over 52 hrs/wk is taking its toll on Indian techies